Jinfang Zheng

Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma

Dafeng Xu, Yu Wang, Xiangmei Liu et al. · Pharmacological Research · 2020 · 77 citations

Life Sciences, Bioinformatics, Oncology +16

ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway

Dafeng Xu, Yu Wang, Jincai Wu et al. · Cell Death and Disease · 2021 · 73 citations · Full text

Medicine, Molecular Biology, Oncology +17

Silencing of long noncoding RNA HOXA11-AS inhibits the Wnt signaling pathway via the upregulation of HOXA11 and thereby inhibits the proliferation, invasion, and self-renewal of hepatocellular carcinoma stem cells

Juncheng Guo, Jinfang Zheng, Jianquan Zhang et al. · Experimental & Molecular Medicine · 2019 · 56 citations · Full text

Medicine, Molecular Biology, Oncology +17

Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile

Dafeng Xu, Xiangmei Liu, Yu Wang et al. · Biomedicine & Pharmacotherapy · 2020 · 39 citations · Full text

Life Sciences, Immunology, Oncology +17

Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial

Ying–Hong Shi, Guohong Han, Jian Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2025 · 39 citations

Medicine, Oncology, Pharmacology +10